ABTNYSELive delayed
$104.49
+1.43+1.39%
SourceCNBCAs ofJul 27, 2026, 8:10 PM
Delayed market data from CNBC. Not investment advice.
Abbott Laboratories is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for ABT · Finnhub.
- Market cap
- $183.57B
- P/E (TTM)
- 28.14
- EPS (TTM)
- $3.1067
- Div. yield
- 2.45%
- 52-week range
- $81.97 – $137.49
- Volume
- —
- Avg volume
- 14.99M
Price history
OHLC candles for ABT · 3mo · 1d · Yahoo Finance · EMA / RSI
+11.33%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth?Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth? Yahoo FinanceBroad market headline — check whether risk appetite shifts.
Watch: ABT · .SPX · .FTSE · .N225
DirectHigh impactGoogle News
Abbott Laboratories (ABT) Q2 2024 Earnings Report - Results, Call & SlidesDirectHigh impactGoogle News
Abbott (ABT) Introduces FDA-Approved SimpleScreen CRC for ColoreDirectHigh impactGoogle News
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed GrowthDirectHigh impactGoogle News
Is Abbott Stock Attractive After Its Earnings and Guidance Update?DirectHigh impactGoogle News
ALP, ABT, HUBC Stocks Hit 52-Week Lows Today: What's Driving The Selloff?DirectHigh impactGoogle News
Abbott Laboratories (ABT) Could Be 14% Undervalued On Mixed Earnings And Growth FocusDirectHigh impactGoogle News
Abbott Stock And 2 Dividend Ideas For Retirement Income